Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Recombinant PAF-AH progresses to phase II for ARDS

June 24, 1997

New orally active oligopeptide antiallergic from Central Drug Res. Inst.

June 23, 1997

Orally active MDP derivative as lead for antiallergic compounds

June 23, 1997

Labopharm and Sepracor to develop new dosage forms of levalbuterol

June 20, 1997

PPL Therapeutics authorized to start phase II trials with transgenic product

June 18, 1997

Dainippon Ink presents new antiallergic/antiasthmatic agent

June 18, 1997

New asthma treatment now available in Canada

June 17, 1997

Milkhaus receives FDA approval to start phase II cystic fibrosis trial

June 17, 1997

IND for gene therapy for cystic fibrosis approved

June 13, 1997

NIH funds high-throughput screening in allergic inflammation and immunology by Cadus

June 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...